Q&A: Key Facts from CDC’s MMWR on Heart Disease in Men

Q&A: Key Facts from CDC’s MMWR on Heart Disease in Men

By Helen Whitaker, Senior Editor

The Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report (MMWR) series has documented heart disease as the leading cause of death for men in the United States, accounting for approximately 1 in every 4 male deaths. Age-adjusted heart disease death rates among men declined overall from 2000 to 2019, although the rate of decline slowed after 2010. CDC surveillance data also indicate elevated prevalence of certain modifiable risk factors among men relative to women. This Q&A summarizes primary findings drawn from MMWR reports and related CDC analyses.

What this means
The MMWR data indicate that declines in male heart disease mortality have slowed in recent years, with reversals observed in some younger age groups. Men show higher reported prevalence of hypertension and current cigarette smoking compared with women. National surveys cited in the reports document lower utilization of routine screening and risk assessment during clinical encounters among male patients. CDC materials associate these patterns with the potential for comprehensive individual, clinical, and community-level approaches to address premature cardiovascular events.

What are the current CVD mortality and prevalence trends specifically for men according to MMWR/CDC data?
Heart disease is the leading cause of death for men in the United States, linked to approximately 1 in every 4 male deaths [1]. Age-adjusted heart disease death rates among men declined overall from 2000–2019, but the rate of decline slowed in later years, with a significant slowdown post-2010 [2]. CDC reports note that CVD mortality declines have slowed or reversed in some younger male age groups [3].

Which modifiable risk factors show the highest prevalence among U.S. men?
The prevalence of hypertension among U.S. men aged 20 and over is approximately 52% [2]. Current cigarette smoking prevalence is higher among men than women, measured at 13.1% for men versus 10.1% for women using 2020 data [1]. MMWR-linked analyses report that men exhibit higher rates of key modifiable risk factors including hypertension, smoking, and physical inactivity compared with women [3].

What prevention and control measures does the CDC report based on these findings?
CDC materials associated with MMWR surveillance identify modifiable risk factors such as hypertension, smoking, obesity, and physical inactivity as central to observed cardiovascular disease patterns in men [2]. The reports link blood pressure control, cholesterol management, smoking cessation, and increased physical activity to the potential to avert the majority of premature CVD events in men [3]. CDC documentation states that routine screening and risk assessment during clinical encounters remain under-utilized among male patients who historically show lower engagement in preventive services [1][3].

Are there notable limitations in the surveillance data for male CVD trends?
MMWR reports primarily rely on national survey data (NHANES, BRFSS) that are self-reported or cross-sectional. These sources have limited granularity on social determinants, occupational exposures, and long-term outcomes specific to diverse male subpopulations. Data lags mean the reports may reflect information collected 2–4 years prior [3].

Limitations
The cited MMWR reports and CDC syntheses draw from self-reported and cross-sectional national survey data with restricted detail on social determinants of health, occupational exposures, and subpopulation-specific long-term outcomes. Surveillance updates commonly lag by two to four years, so published figures may not capture the most recent shifts in male cardiovascular disease patterns.